P.B. de Sonnaville

Induction therapy with a combination of DMARDs is better than methotrexate monotherapy: first results of the tREACH trial

P.H. de Jong, Johanna M. W. Hazes, P J Barendregt et al. · Annals of the Rheumatic Diseases · 2012 · 137 citations · Full text

Medicine, Internal Medicine, Pharmacotherapy +16

Randomised comparison of initial triple DMARD therapy with methotrexate monotherapy in combination with low-dose glucocorticoid bridging therapy; 1-year data of the tREACH trial

P.H. de Jong, J. M. W. Hazes, Huub KH Han et al. · Annals of the Rheumatic Diseases · 2014 · 125 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +15

Association of Low Baseline Levels of Erythrocyte Folate With Treatment Nonresponse at Three Months in Rheumatoid Arthritis Patients Receiving Methotrexate

Maurits C. F. J. de Rotte, Pascal H P de Jong, Saskia M.F. Pluijm et al. · Arthritis & Rheumatism · 2013 · 43 citations

Medicine, Clinical Sciences, Internal Medicine +17

Response to glucocorticoids at 2 weeks predicts the effectiveness of DMARD induction therapy at 3 months: post hoc analyses from the tREACH study

Pascal H P de Jong, R. A. M. Quax, Margriet Huisman et al. · Annals of the Rheumatic Diseases · 2012 · 19 citations

Medicine, Clinical Sciences, Pharmacotherapy +16